CD8A and neoplasm: The tumor-specific CD8+ T cell response was tracked by intravenously transferring fluorescently-labeled naïve CD8+ T cells (L-selectinhi CD44low) expressing HA-specific transgenic T cell receptors (derived from transgenic Clone 4 mice [21, 22]).